Jaiswal, Anil Kumar <br/><br/>
Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.  [electronic resource] 

 -  International journal of antimicrobial agents  Dec 2016 
 - 695-702 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7913 
<br/><br/><label>Standard No.: </label>10.1016/j.ijantimicag.2016.09.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiprotozoal Agents--administration & dosage<br/>Cell Line<br/>Chalcone--administration & dosage<br/>Cricetinae<br/>DNA, Protozoan--genetics<br/>DNA, Ribosomal--genetics<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical--methods<br/>Female<br/>Flow Cytometry--methods<br/>Genes, Reporter<br/>Hydrazones--administration & dosage<br/>Leishmania donovani--drug effects<br/>Leishmaniasis, Visceral--drug therapy<br/>Luminescent Proteins--analysis<br/>Macrophages--parasitology<br/>Male<br/>Mice<br/>RNA, Ribosomal, 18S--genetics<br/>Recombination, Genetic<br/>Staining and Labeling--methods<br/>Treatment Outcome